A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride

Updated 05/07/2024

Status Recruiting

Clinical Trial Summary

This is an open, multi-cohort, exploratory phase II study on the safety and efficacy of TQB3616 combined with Anlotinib hydrochloride capsules or standard chemotherapy in the treatment of advanced lung cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04924192
Study type	Interventional
Source	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Contact	Yongsheng Li, Doctor
Phone	18980602258
Email	wangys@wchscu.cn
Status	Recruiting
Phase	Phase 2
Start date	August 18, 2021
Completion date	December 30, 2023

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT03776253` - Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer	N/A
	Recruiting	`NCT05886439` - LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer	Phase 1
	Not yet recruiting	`NCT06374160` - Exercise in Patients With Advanced Non-small Cell Lung Cancer	N/A
	Active, not recruiting	`NCT04819997` - A Nurse-Led Intervention for Fear of Progression in Advanced Cancer	N/A
	Recruiting	`NCT05256290` - Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations	Phase 1/Phase 2
	Recruiting	`NCT05274451` - A Study to Investigate LYL797 in Adults With Solid Tumors	Phase 1
	Active, not recruiting	`NCT04785287` - Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies	Phase 1/Phase 2
	Completed	`NCT05342571` - A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer	N/A
	Completed	`NCT04229381` - Resiliency Among Older Adults Receiving Lung Cancer Treatment	N/A
	Active, not recruiting	`NCT05640765` - BeWell360-CG Care Model: Health and Wellness Coaching to Support Caregivers of Patients Living With Advanced Lung Cancers	N/A
	Not yet recruiting	`NCT04702009` - Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer	Phase 2/Phase 3
	Active, not recruiting	`NCT03707938` - Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer	Phase 1
	Recruiting	`NCT05969860` - At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer	Phase 2
	Recruiting	`NCT06343402` - Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer	Phase 1